MRNA

Placental errors may explain gestational diabetes risks, study finds

“By understanding how gestational diabetes disrupts the placenta at the molecular level, we can begin to imagine new ways to protect the offspring,” said Dr. Tal Schiller of HUJI Faculty of Medicine.

An opportunity arises to pause, breathe, and listen inward
 The researchers from Tel Aviv University (TAU) and the Israel Institute for Biological Research in the city of Nes Ziona.

Israeli researchers develop world-first mRNA vaccine against deadly bacteria

 The research team (Left to right) Prof. Dan Peer, Dr. Inbal Hazan-Halevy & Shani Benarroch.

Israeli researchers develop world's first mRNA-based vaccine against bacterium

 A 3D model of mRNA is displayed on the day of opening of German pharmaceuticals company BioNtech mRNA vaccine manufacturing plant to serve the African market in Kigali, Rwanda December 18, 2023.

Hebrew University study finds zebrafish provides clues to RNA's role in embryo formation


World's first: Patients treated with new cancer vaccine

COVID-19 vaccines inspired UK doctors to use mRNA for precise, less toxic cancer treatment. The results seem promising for all types of cancer.

A coronavirus vaccine dose is seen being administered at a Meuhedet vaccination center in Jerusalem, on February 16, 2021.

Jewish American scientist wins Nobel Prize in Medicine for COVID vaccines

The medicine prize kicks off this year's awards with the remaining five to be unveiled in the coming days.

 Nobel prize

3D printed microneedle patches can help bring vaccines to the masses

The researchers decided to work with a novel type of vaccine delivery based on patches about the size of a thumbnail that contain hundreds of microneedles.

 Vaccination

What's behind the recent Moderna cancer ‘vaccine’ announcement?

World-renowned Hebrew University cancer researcher urges caution about claimed ‘breakthrough’ and terminology.

A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020

mRNA could make flu vaccines more effective - here's how

The World Health Organization reported that as many as 5 million people suffer from severe cases of influenza each year.

THE MRNA TECHNIQUE may mean that future pandemics can be dealt with far more quickly.

Moderna says new RSV vaccine 84% effective in older adults

Moderna intends to submit the RSV vaccine for regulatory approval in the first half of 2023.

A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020

Israel researchers discover 100,000 new RNA viruses

RNA viruses infect cells by injecting RNA into the cytoplasm of the host cells to transcribe and replicate viral proteins.

3D scan of SARS-CoV-2 virus particles created by design lab Nanographics

Sheba Medical Center and the US NIH to establish Pandemic Research Institute

The institute will work with the NIH and research innovative techniques to discover new pathogens and predict future threats.

 Sheba Medical Center and the NIH launch new research center.

Moderna to launch phase III trials for mRNA cancer vaccine

The mRNA technology used in Moderna's cancer vaccine is built off of what was used in their COVID-19 vaccine.

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020

Moderna sues Pfizer and BioNTech over COVID-19 vaccine

Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology.

Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.

COVID-19 mRNA vaccines safe to use during pregnancy, study finds

Four percent more unvaccinated pregnant women had health complications than pregnant women who received the mRNA vaccine against COVID-19 after a week in a new study.

 Vials representing the mRNA coronavirus disease (COVID-19) vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG) are seen displayed at its booth at the 2021 China International Fair for Trade in Services (CIFTIS) in Beijing, China September 3, 2021.